当前位置：首页 > 文献互助 > 互助详情

Withdrawal pain following patients discontinuing Trk inhibitors复制

用户6X7Ch8WUQ_gI 13天前 33 10 已完结

1. 系统已在2025-11-25 17:52:16对应助文件进行删除

2. 如有需要请重新发布求助信息

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: 10.1177/10781552241279196复制

文献链接: https://journals.sagepub.com/doi/10.1177/10781552241279196复制

其他信息:

出版社: SAGE Publications
作者: Alan Chin; Sheila Lindsay; Emily K Bergsland; Hyunseok Kang
全文下载地址: https://journals.sagepub.com/doi/pdf/10.1177/10781552241279196

上一篇：Discovery of novel indazole derivatives as second-generation TRK inhibitors

下一篇：Pain Signaling by GPCRs and RTKs

互助时间线

2025-11-19 10:50:41 [完结求助]

楼主确认了用户u953h46epACF应助的文件是正确的, 求助状态变成 已完结

2025-11-18 17:52:16 [上传文件]

用户u953h46epACF上传了文件(pdf 238.85 KB), 求助状态变成 待确认

2025-11-18 17:07:29 [发起求助]

最新发布的求助

Index Structures for Biological Sequences 1小时前
Drugging the efferocytosis process: concepts and opportunities. 1小时前
Characterization of CAR-T cellular kinetics and efficacy in solid tumor patients with and without prior lymphodepletion chemotherapy using a PBPK-PD model 3小时前
Comprehensive 3d Transition Metal Single‐Atom Modulation Tunes Ni‐MOF D‐Band for Alkaline OER 4小时前
Decoupling of nitrogen, phosphorus, and carbon release from fine and coarse roots during 7 years of decomposition 4小时前
A meta-analysis of albuminuria as a surrogate endpoint for kidney failure 4小时前
Tetrahedral Framework Nucleic Acid-Based Delivery of miR-34a Inhibitor for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis. 4小时前
A practical guide to large-scale docking 5小时前
Bicyclo[1.1.1]pentane-Derived Building Blocks for Click Chemistry 5小时前
Expanding Therapeutic Horizons in Parkinson's Disease Through MicroRNA-Based Interventions: A Comprehensive Review 5小时前
{Formulated Preparations- Specific Monographs} Rivastigmine Capsules - british pharmacopoeia[1731412457.779041.html] 6小时前
Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China 7小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com